Chromium infusion in hospitalized patients with severe insulin resistance: A retrospective analysis

Endocrine Practice

Volumn 18, Issue 3, 2012, Pages 394-398

  Drake, Tyler C ^a   Rudser, Kyle D ^b   Seaquist, Elizabeth R ^a   Saeed, Asad ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMIUM CHLORIDE; GLUCOSE;

ADULT; CLINICAL ARTICLE; CONTINUOUS INFUSION; DRUG EFFECT; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HOSPITAL PATIENT; HUMAN; HYPERGLYCEMIA; INFUSION RATE; INSULIN INFUSION; INSULIN RESISTANCE; MALE; MEDICAL RECORD REVIEW; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECOMMENDED DRUG DOSE; RETROSPECTIVE STUDY; REVIEW; TREATMENT DURATION; UNIVERSITY HOSPITAL;

EID: 84861028584     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11243.OR     Document Type: Review

References (18)

1. Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE. Hyperglycemia: An independent marker of in-hospital mortality in patients with undiagnosed diabe-tes. J Clin Endocrinol Metab. 2002;87:978-982.
2. Montori VM, Bistrian BR, McMahon MM. Hyper-glycemia in acutely ill patients. JAMA. 2002;288: 2167-2169.
3. Rizza RA, Mandarino LJ, Gerich JE. Dose-response char-acteristics for effects of insulin on production and utiliza-tion of glucose in man. Am J Physiol. 1981;240:E630-E639.
4. Via M, Scurlock C, Raikhelkar J, Di Luozzo GD, Mechanick JI. Chromium infusion reverses extreme insu-lin resistance in a cardiothoracic ICU patient. Nutr Clin Pract. 2008;23:325-328.
5. Phung OJ, Quercia RA, Keating K, et al. Improved glu-cose control associated with i.v. chromium administration in two patients receiving enteral nutrition. Am J Health Syst Pharm. 2010;67:535-541.
6. Davis CM, Vincent JB. Chromium oligopeptide activates insulin receptor tyrosine kinase activity. Biochemistry. 1997;36:4382-4385.
7. Anderson RA. Chromium and insulin resistance. Nutr Res Rev. 2003;16:267-275.
8. R Development Core Team (2010). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria. ISBN 3-900051-07-0. Available at: Http://www.R-project.org/.
9. Vincent JB. Elucidating a biological role for chromium at a molecular level. Acc Chem Res. 2000;33:503-510.
10. Trumbo P, Yates AA, Schlicker S, Poos M. Dietary refer-ence intakes: Vitamin A, vitamin K, arsenic, boron, chro-mium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc. J Am Diet Assoc. 2001; 101:294-301.
11. Stearns DM, Wise JP Sr, Patierno SR, Wetterhahn KE. Chromium(III) picolinate produces chromosome damage in Chinese hamster ovary cells. FASEB J. 1995;9:1643-1648.
12. Speetjens JK, Collins RA, Vincent JB, Woski SA. The nutritional supplement chromium(III) tris(picolinate) cleaves DNA. Chem Res Toxicol. 1999;12:483-487.
13. Blasiak J, Kowalik J. A comparison of the in vitro geno-toxicity of tri- And hexavalent chromium. Mutat Res. 2000; 469: 135-145.
14. Anderson RA, Bryden NA, Polansky MM. Lack of toxic-ity of chromium chloride and chromium picolinate in rats. J Am Coll Nutr. 1997;16:273-279.
15. Wasser WG, Feldman NS, D'Agati VD. Chronic renal failure after ingestion of over-the-counter chromium pico-linate. Ann Intern Med. 1997;126:410.
16. Cerulli J, Grabe DW, Gauthier I, Malone M, McGoldrick MD. Chromium picolinate toxicity. Ann Pharmacother. 1998;32:428-431.
17. Wani S, Weskamp C, Marple J, Spry L. Acute tubular necrosis associated with chromium picolinate-containing dietary supplement. Ann Pharmacother. 2006;40:563-566.
18. Ravina A, Slezak L, Mirsky N, Bryden NA, Anderson RA. Reversal of corticosteroid-induced diabetes melli-tus with supplemental chromium. Diabet Med. 1999;16: 164-167.